Imiquimod for Cell Culture

<strong>Imiquimod for Cell Culture</strong>_x000D_ <strong>Catalog number:</strong> B2015974_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 240.3_x000D_ <strong>Supplied as:</strong> Powder_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> RT_x000D_ <strong>Keywords:</strong> Imiquimod for cell culture, 98%_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Farid MRA, Lugão HB, Julio TA, Donadi EA, Bueno Filho R, Roselino AM. Imiquimod-Associated Pemphigus Foliaceus Am J Ther. 2022 Nov-Dec 01;29(6):e716-e719._x000D_ 2: Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice Biol Res. 2020 Oct 20;53(1):48._x000D_ 3: Chuang KC, Chang CR, Chang SH, Huang SW, Chuang SM, Li ZY, Wang ST, Kao JK, Chen YJ, Shieh JJ. Imiquimod-induced ROS production disrupts the balance of mitochondrial dynamics and increases mitophagy in skin cancer cells J Dermatol Sci. 2020 Jun;98(3):152-162._x000D_ 4: Fonseca BO, Possati-Resende JC, Salcedo MP, Schmeler KM, Accorsi GS, Fregnani JHTG, Antoniazzi M, Pantano NP, Santana IVV, Matsushita GM, Dos Reis R. Topical Imiquimod for the Treatment of High-Grade Squamous Intraepithelial Lesions of the Cervix: A Randomized Controlled Trial Obstet Gynecol. 2021 Jun 1;137(6):1043-1053._x000D_ 5: Avallone G, Merli M, Dell'Aquila C, Quaglino P, Ribero S, Zalaudek I, Conforti C. Imiquimod-side effects in the treatment of periocular skin cancers: A review of the literature Dermatol Ther. 2022 Apr;35(4):e15326._x000D_ 6: Trčko K. Imiquimod-associated erythema multiforme Acta Dermatovenerol Alp Pannonica Adriat. 2020 Mar;29(1):47-49._x000D_ 7: Garcia-Mouronte E, Berna-Rico E, de Nicolas-Ruanes B, Azcarraga-Llobet C, Alonso-Martinez de Salinas L, Bea-Ardebol S. Imiquimod as Local Immunotherapy in the Management of Premalignant Cutaneous Conditions and Skin Cancer Int J Mol Sci. 2023 Jun 29;24(13):10835._x000D_ 8: Abreu EP, Schwan NV, Gontijo JRV, Bittencourt FV. Imiquimod-induced extensive plaque psoriasis Int J Dermatol. 2023 Dec;62(12):e614-e615._x000D_ 9: Safadi MG, Hassan S, Patel V, Viglione M, Zahner SL. Imiquimod-induced hypertrophic lupus erythematosus-like reaction Dermatol Online J. 2022 Aug 15;28(4)._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/34614305">10: Yu H, Cen J, Lin X, Cheng H, Seifert O. Imiquimod induced vitiligo-like lesions-A consequence of modified melanocyte function Immun Inflamm Dis. 2022 Jan;10(1):70-77. </a>_x000D_ _x000D_ <strong>Products Related to Imiquimod for Cell Culture can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>